Developing nanovaccines to treat pancreatic cancer
Official title: Anticancer ELNP nanovaccines for curative treatmentof pancreatic cancer
Funded at Case Western Reserve University · NIH-11040015 · Data updated 2026-11-12
This study is testing a new type of vaccine made from tiny particles to help boost the immune system's fight against pancreatic cancer, and it’s designed for patients with this tough-to-treat disease.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Case Western Reserve University NIH-funded |
| Lab location | 1 site (Cleveland, United States) |
| Project start | December 1, 2024 |
| Project end | November 30, 2029 |
| Funding year | 2025 |
| Award (this year) | $654,681 |
| NIH project number | 1R01CA297621-01 |
| Project ID | NIH-11040015 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with pancreatic ductal adenocarcinoma who are seeking innovative treatment options.
✕Less likely to help
Patients with other types of cancer or those who are not diagnosed with pancreatic ductal adenocarcinoma may not benefit from this research.
What this research studies
This research focuses on creating advanced nanovaccines using specialized lipid nanoparticles to treat pancreatic ductal adenocarcinoma (PDAC), a highly aggressive form of cancer. The approach aims to enhance the immune response against cancer cells by targeting specific mutations associated with PDAC. By combining these nanovaccines with immune checkpoint inhibitors, the research seeks to improve treatment effectiveness and patient outcomes. Additionally, the study will employ innovative imaging technology to monitor the treatment's impact in real-time, allowing for adjustments to the therapy as needed.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for pancreatic cancer, potentially increasing survival rates and improving quality of life for patients.
How similar studies have gone: While the use of nanovaccines in cancer treatment is a relatively novel approach, preliminary studies in similar areas have shown promising results in enhancing immune responses against tumors.
Where this research is happening
-
Case Western Reserve University
Cleveland, United States Active
Researchers
- Principal investigator: Lu, Zheng-Rong — Case Western Reserve University
- Study coordinator: Lu, Zheng-Rong
Related research
Other NIH-funded projects on the same topics.
-
Microbial Dysbiosis and Its Role in Pancreatic Cancer
A doctor-researcher team at Northwestern University is studying how gut bacteria influence pancreatic cancer and its response to immunotherapy to find new ways to help patients.
-
Targeting aberrant enhancer landscapes in pancreatic cancer
A patient-facing look at a project that aims to understand how pancreatic cancer changes its cell identity and what that means for treatment.
-
Exosome-based microRNA biomarkers for early, non-invasive detection of pancreatic cancer
A study to develop a blood test that uses tiny RNA signals in exosomes to detect pancreatic cancer early, aiming to help people at risk or with early disease.
-
Exosome-based microRNA biomarkers for early detection of pancreatic cancer
A patient-friendly look at a study using tiny blood-based RNA markers inside exosomes to catch pancreatic cancer early without invasive procedures.
-
Programmable implanted living materials to fight pancreatic cancer
A patient-facing program will explore a safe, implantable living material that delivers sequential immunotherapies directly to pancreatic tumors to help fight cancer.
-
Targeting how platelets and pancreatic cancer talk to each other
A study exploring whether blocking the interaction between platelets and pancreatic cancer cells could slow cancer growth and spread and help identify new biomarkers.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.